Where Will VICI Properties Be in 5 Years?
VICI Properties (NYSE:VICI) is a real estate investment trust focused…
Sell
26
LFST Quote, Financials, Valuation and Earnings
Last price:
$5.72
Seasonality move
:
-2.15%
Day range:
$5.78 - $6.03
52-week range:
$4.64 - $8.61
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.74x
P/B ratio:
1.57x
Volume:
1.7M
Avg. volume:
1.8M
1-year change:
4.07%
Market cap:
$2.3B
Revenue:
$1.3B
EPS (TTM):
-$0.10
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LFST
LifeStance Health Group
|
$332.9M | $0.01 | 11.21% | -95.93% | $8.86 |
|
BKD
Brookdale Senior Living
|
$816.9M | -$0.14 | 4.88% | -13.75% | $7.70 |
|
DVA
DaVita
|
$3.2B | $2.02 | 5.28% | 10.44% | $162.92 |
|
ENSG
Ensign Group
|
$1.2B | $1.49 | 17.73% | 27.21% | $165.17 |
|
PNTG
Pennant Group
|
$201.5M | $0.24 | 24.62% | 48.61% | $33.60 |
|
SGRY
Surgery Partners
|
$777.1M | $0.05 | 7.29% | 31.79% | $31.36 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LFST
LifeStance Health Group
|
$5.88 | $8.86 | $2.3B | -- | $0.00 | 0% | 1.74x |
|
BKD
Brookdale Senior Living
|
$6.57 | $7.70 | $1.5B | -- | $0.00 | 0% | 0.48x |
|
DVA
DaVita
|
$137.78 | $162.92 | $10.4B | 13.66x | $0.00 | 0% | 0.90x |
|
ENSG
Ensign Group
|
$149.80 | $165.17 | $8.6B | 28.32x | $0.06 | 0.16% | 1.98x |
|
PNTG
Pennant Group
|
$28.83 | $33.60 | $993.7M | 37.93x | $0.00 | 0% | 1.28x |
|
SGRY
Surgery Partners
|
$23.36 | $31.36 | $3B | -- | $0.00 | 0% | 0.93x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LFST
LifeStance Health Group
|
15.94% | 1.095 | 10.67% | 1.32x |
|
BKD
Brookdale Senior Living
|
96.71% | -1.110 | 294.12% | 0.54x |
|
DVA
DaVita
|
102.82% | 1.528 | 70.83% | 1.12x |
|
ENSG
Ensign Group
|
6.99% | 0.754 | 1.99% | 1.32x |
|
PNTG
Pennant Group
|
14.74% | 0.809 | 5.93% | 1.14x |
|
SGRY
Surgery Partners
|
67.11% | 0.491 | 72.6% | 1.40x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LFST
LifeStance Health Group
|
$109.8M | $1.6M | -2.07% | -2.48% | 0.48% | -$10.3M |
|
BKD
Brookdale Senior Living
|
$223.1M | $31.4M | -5.66% | -86.4% | -0.67% | -$18.4M |
|
DVA
DaVita
|
$983.9M | $433.3M | 7.42% | 38.96% | 13.07% | $36.8M |
|
ENSG
Ensign Group
|
$188.1M | $101.4M | 16.28% | 17.64% | 9.26% | $29.3M |
|
PNTG
Pennant Group
|
$29.4M | $12.7M | 8.55% | 10.97% | 6% | -$23.2M |
|
SGRY
Surgery Partners
|
$161.9M | $89.6M | -2.86% | -5.45% | 7.98% | -$16.7M |
LifeStance Health Group vs. Competitors
-
Which has Higher Returns LFST or BKD?
Brookdale Senior Living has a net margin of 0.21% compared to LifeStance Health Group's net margin of -7.98%. LifeStance Health Group's return on equity of -2.48% beat Brookdale Senior Living's return on equity of -86.4%.
Company Gross Margin Earnings Per Share Invested Capital LFSTLifeStance Health Group32.97% -- $1.7B BKDBrookdale Senior Living27.41% -$0.28 $4.5B -
What do Analysts Say About LFST or BKD?
LifeStance Health Group has a consensus price target of $8.86, signalling upside risk potential of 50.63%. On the other hand Brookdale Senior Living has an analysts' consensus of $7.70 which suggests that it could grow by 17.2%. Given that LifeStance Health Group has higher upside potential than Brookdale Senior Living, analysts believe LifeStance Health Group is more attractive than Brookdale Senior Living.
Company Buy Ratings Hold Ratings Sell Ratings LFSTLifeStance Health Group5 1 0 BKDBrookdale Senior Living2 1 0 -
Is LFST or BKD More Risky?
LifeStance Health Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Brookdale Senior Living has a beta of 0.813, suggesting its less volatile than the S&P 500 by 18.674%.
-
Which is a Better Dividend Stock LFST or BKD?
LifeStance Health Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Brookdale Senior Living offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeStance Health Group pays -- of its earnings as a dividend. Brookdale Senior Living pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LFST or BKD?
LifeStance Health Group quarterly revenues are $333M, which are smaller than Brookdale Senior Living quarterly revenues of $813.9M. LifeStance Health Group's net income of $709K is higher than Brookdale Senior Living's net income of -$65M. Notably, LifeStance Health Group's price-to-earnings ratio is -- while Brookdale Senior Living's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeStance Health Group is 1.74x versus 0.48x for Brookdale Senior Living. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSTLifeStance Health Group1.74x -- $333M $709K BKDBrookdale Senior Living0.48x -- $813.9M -$65M
-
Which has Higher Returns LFST or DVA?
DaVita has a net margin of 0.21% compared to LifeStance Health Group's net margin of 5.05%. LifeStance Health Group's return on equity of -2.48% beat DaVita's return on equity of 38.96%.
Company Gross Margin Earnings Per Share Invested Capital LFSTLifeStance Health Group32.97% -- $1.7B DVADaVita30.52% $2.00 $11.4B -
What do Analysts Say About LFST or DVA?
LifeStance Health Group has a consensus price target of $8.86, signalling upside risk potential of 50.63%. On the other hand DaVita has an analysts' consensus of $162.92 which suggests that it could grow by 18.25%. Given that LifeStance Health Group has higher upside potential than DaVita, analysts believe LifeStance Health Group is more attractive than DaVita.
Company Buy Ratings Hold Ratings Sell Ratings LFSTLifeStance Health Group5 1 0 DVADaVita1 8 0 -
Is LFST or DVA More Risky?
LifeStance Health Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DaVita has a beta of 1.107, suggesting its more volatile than the S&P 500 by 10.674%.
-
Which is a Better Dividend Stock LFST or DVA?
LifeStance Health Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DaVita offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeStance Health Group pays -- of its earnings as a dividend. DaVita pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LFST or DVA?
LifeStance Health Group quarterly revenues are $333M, which are smaller than DaVita quarterly revenues of $3.2B. LifeStance Health Group's net income of $709K is lower than DaVita's net income of $162.9M. Notably, LifeStance Health Group's price-to-earnings ratio is -- while DaVita's PE ratio is 13.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeStance Health Group is 1.74x versus 0.90x for DaVita. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSTLifeStance Health Group1.74x -- $333M $709K DVADaVita0.90x 13.66x $3.2B $162.9M
-
Which has Higher Returns LFST or ENSG?
Ensign Group has a net margin of 0.21% compared to LifeStance Health Group's net margin of 6.84%. LifeStance Health Group's return on equity of -2.48% beat Ensign Group's return on equity of 17.64%.
Company Gross Margin Earnings Per Share Invested Capital LFSTLifeStance Health Group32.97% -- $1.7B ENSGEnsign Group16.04% $1.37 $2.1B -
What do Analysts Say About LFST or ENSG?
LifeStance Health Group has a consensus price target of $8.86, signalling upside risk potential of 50.63%. On the other hand Ensign Group has an analysts' consensus of $165.17 which suggests that it could grow by 10.26%. Given that LifeStance Health Group has higher upside potential than Ensign Group, analysts believe LifeStance Health Group is more attractive than Ensign Group.
Company Buy Ratings Hold Ratings Sell Ratings LFSTLifeStance Health Group5 1 0 ENSGEnsign Group4 1 0 -
Is LFST or ENSG More Risky?
LifeStance Health Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ensign Group has a beta of 1.032, suggesting its more volatile than the S&P 500 by 3.167%.
-
Which is a Better Dividend Stock LFST or ENSG?
LifeStance Health Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ensign Group offers a yield of 0.16% to investors and pays a quarterly dividend of $0.06 per share. LifeStance Health Group pays -- of its earnings as a dividend. Ensign Group pays out 4.59% of its earnings as a dividend. Ensign Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios LFST or ENSG?
LifeStance Health Group quarterly revenues are $333M, which are smaller than Ensign Group quarterly revenues of $1.2B. LifeStance Health Group's net income of $709K is lower than Ensign Group's net income of $80.3M. Notably, LifeStance Health Group's price-to-earnings ratio is -- while Ensign Group's PE ratio is 28.32x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeStance Health Group is 1.74x versus 1.98x for Ensign Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSTLifeStance Health Group1.74x -- $333M $709K ENSGEnsign Group1.98x 28.32x $1.2B $80.3M
-
Which has Higher Returns LFST or PNTG?
Pennant Group has a net margin of 0.21% compared to LifeStance Health Group's net margin of 3.71%. LifeStance Health Group's return on equity of -2.48% beat Pennant Group's return on equity of 10.97%.
Company Gross Margin Earnings Per Share Invested Capital LFSTLifeStance Health Group32.97% -- $1.7B PNTGPennant Group14% $0.22 $375.5M -
What do Analysts Say About LFST or PNTG?
LifeStance Health Group has a consensus price target of $8.86, signalling upside risk potential of 50.63%. On the other hand Pennant Group has an analysts' consensus of $33.60 which suggests that it could grow by 16.55%. Given that LifeStance Health Group has higher upside potential than Pennant Group, analysts believe LifeStance Health Group is more attractive than Pennant Group.
Company Buy Ratings Hold Ratings Sell Ratings LFSTLifeStance Health Group5 1 0 PNTGPennant Group2 2 0 -
Is LFST or PNTG More Risky?
LifeStance Health Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Pennant Group has a beta of 1.515, suggesting its more volatile than the S&P 500 by 51.458%.
-
Which is a Better Dividend Stock LFST or PNTG?
LifeStance Health Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pennant Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeStance Health Group pays -- of its earnings as a dividend. Pennant Group pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LFST or PNTG?
LifeStance Health Group quarterly revenues are $333M, which are larger than Pennant Group quarterly revenues of $209.8M. LifeStance Health Group's net income of $709K is lower than Pennant Group's net income of $7.8M. Notably, LifeStance Health Group's price-to-earnings ratio is -- while Pennant Group's PE ratio is 37.93x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeStance Health Group is 1.74x versus 1.28x for Pennant Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSTLifeStance Health Group1.74x -- $333M $709K PNTGPennant Group1.28x 37.93x $209.8M $7.8M
-
Which has Higher Returns LFST or SGRY?
Surgery Partners has a net margin of 0.21% compared to LifeStance Health Group's net margin of -4.86%. LifeStance Health Group's return on equity of -2.48% beat Surgery Partners's return on equity of -5.45%.
Company Gross Margin Earnings Per Share Invested Capital LFSTLifeStance Health Group32.97% -- $1.7B SGRYSurgery Partners20.86% -$0.30 $7.1B -
What do Analysts Say About LFST or SGRY?
LifeStance Health Group has a consensus price target of $8.86, signalling upside risk potential of 50.63%. On the other hand Surgery Partners has an analysts' consensus of $31.36 which suggests that it could grow by 34.26%. Given that LifeStance Health Group has higher upside potential than Surgery Partners, analysts believe LifeStance Health Group is more attractive than Surgery Partners.
Company Buy Ratings Hold Ratings Sell Ratings LFSTLifeStance Health Group5 1 0 SGRYSurgery Partners8 3 0 -
Is LFST or SGRY More Risky?
LifeStance Health Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Surgery Partners has a beta of 1.931, suggesting its more volatile than the S&P 500 by 93.143%.
-
Which is a Better Dividend Stock LFST or SGRY?
LifeStance Health Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Surgery Partners offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeStance Health Group pays -- of its earnings as a dividend. Surgery Partners pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LFST or SGRY?
LifeStance Health Group quarterly revenues are $333M, which are smaller than Surgery Partners quarterly revenues of $776M. LifeStance Health Group's net income of $709K is higher than Surgery Partners's net income of -$37.7M. Notably, LifeStance Health Group's price-to-earnings ratio is -- while Surgery Partners's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeStance Health Group is 1.74x versus 0.93x for Surgery Partners. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LFSTLifeStance Health Group1.74x -- $333M $709K SGRYSurgery Partners0.93x -- $776M -$37.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Exxon Stock Be in 5 Years?
For sure Exxon Mobil (NYSE: XOM) is no hyped-up AI…
How High Will Dollar General Stock Go?
Shares of Dollar General (NYSE:DG) have risen significantly in recent…
Stock Ideas
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
64
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
59
SBET alert for Jun 10
SharpLink Gaming [SBET] is up 14.34% over the past day.
Buy
85
ASTS alert for Jun 10
AST SpaceMobile [ASTS] is up 2.58% over the past day.
Buy
69
CCJ alert for Jun 10
Cameco [CCJ] is down 4.56% over the past day.
